Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ascent Solar Technologies, Inc. Completes First Delivery of New, Increased Efficiency Material for Lifecycle Performance Capabilities Testing in Space Environments
-
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
-
Dragonfly Energy Partners with Connexa, Fueling Industrial Solar Power System Applications
-
PyroGenesis Receives New U.S. Patent for Its Innovative NexGen™ Plasma Atomization Metal Powder Production Technology for Use in Additive Manufacturing and 3D Printing
-
ExxonMobil to Build CCS Pilot Plant with FuelCell Energy Using Carbonate Fuel Cell Technology
-
Venus Concept Announces New International Distributors in the United Kingdom and India to Continue Global Growth
-
Form 8.3 - Young & Co's Brewery plc
-
BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes
-
IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilm®
-
LCS promotes David Mercugliano to lead business development strategy
-
Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on Dialysis
-
Eloro Resources Intersects 279.22 g Ag/t, 0.47% Pb and 0.43% Sn (339.82g Ag eq/t) over 62.84m in Definition Drilling at the Iska Iska Project, Potosi Department, Southwestern Bolivia
-
U.S. Food and Drug Administration Issues Complete Response Letter for Cosibelimab Solely Due to Inspection Findings at Third-Party Manufacturer
-
Cipher Mining Purchases 7.1 EH/s of New Miners and Option to Purchase an Additional 8.7 EH/s of Latest Generation Miners from Bitmain
-
Xali Gold Enters Into a Rent to Purchase Agreement on the SDA Plant in Mexico
-
Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™
-
Successful Transfer of New Drug Application (NDA), Acknowledged by U.S. FDA, from Former Zosano Pharma to Emergex for Investigational Microneedle-Based Drug Delivery Patch
-
Red Pine Intersects Significant Mineralization within a gap of the existing resource – 3.80 g/t gold over 36.94m including 11.01 g/t gold over 5.60m
-
Universal Stainless Engages EisnerAmper as New Audit Firm
-
Smart for Life Names Two Executives to Senior Management Team
-
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Fourth Quarter of 2023
-
Plus Updates Financial and Cash Guidance for 2024
-
Helium Evolution Announces Second Joint Well Encountered Helium; Completion and Testing to Proceed
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Usdtone Secures $6 Million Strategic Investment, Expediting the Creation of Global Crypto Exchange
-
HUB Cyber Security Seals New Agreement with Prominent International Entertainment Corporation
-
Akero Therapeutics Announces First Patients Dosed in Efruxifermin Phase 3 SYNCHRONY Program
-
Cobo Achieves ISO 27001 Certification, Showcasing Strengthened Information Security in Institutional Custody
-
2024 Outlook: Expected Marijuana Rescheduling Will Help Stabilize, Revitalize Cannabis Businesses
-
Revive Therapeutics Collaborates with Attwill Medical Solutions for the Clinical and Commercial Development of a Novel Lyophilized Formulation of Bucillamine
-
Akoustis Receives Wi-Fi 6E Design Win from Tier-1 Consumer AP Customer
-
SRAX SHAREHOLDER LETTER
-
Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)
-
Applied UV Announces Successful Integration of Its PURO UV Disinfection and Airocide Food Preservation Units to Optimize Cost Reduction and Expand Global Growth Opportunities
-
Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis
-
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19
-
Sonoco Implementing Price Increase for all Paperboard Converted Products
-
Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
-
New DISQO Insights: Brands Face Consumer Apprehension Headwinds in 2024
-
Webuy Global to Ring NASDAQ Opening Bell Today
-
Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens
-
Sunstone Therapies Announces Publication of Positive Phase 2 Study Results in Cancer
-
KopenTech announces new All-to-All trading protocol for CLO securities, completes first client trades using protocol
-
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy®
-
NexGami's Beta Test Exceeds Expectations, Draws in 200K Extra Players and Mints Nearly 72K NFTs in a Day
-
NexGami's Beta Test Exceeds Expectations, Draws in 200K Extra Players and Mints Nearly 72K NFTs in a Day
-
Boussard & Gavaudan Investment Management LLP: Form 8.3 - Smart Metering Systems plc
-
Form 8.3 - [musicMAGPIE PLC - 15 12 2023] - (CGAML)
-
Form 8.3 - Equals Group plc
-
Net Asset Value(s)
